HI
AGN

Hudock Inc’s Allergan plc AGN Stock Holding History

Hudock Inc’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-153
Closed -$25K – 738
2018
Q1 		$25K Buy
153
+1
+0.7% +$168 0.01% 333
2017
Q4 		$25K Sell
152
-421
-73% -$75.5K 0.01% 321
2017
Q3 		$117K Buy
573
+2
+0.4% +$465 0.05% 123
2017
Q2 		$138K Buy
571
+2
+0.4% +$470 0.07% 117
2017
Q1 		$136K Sell
569
-80
-12% -$18.6K 0.07% 114
2016
Q4 		$136K Sell
649
-59
-8% -$12.2K 0.08% 116
2016
Q3 		$163K Sell
708
-177
-20% -$43.3K 0.09% 102
2016
Q2 		$204K Buy
885
+99
+13% +$22.8K 0.11% 88
2016
Q1 		$210K Buy
786
+150
+24% +$42.9K 0.12% 90
2015
Q4 		$198K Hold
636
– – 0.09% 93
2015
Q3 		$172K Hold
636
– – 0.08% 96
2015
Q2 		$193K Hold
636
– – 0.09% 92
2015
Q1 		$189K Buy
+636
New +$181K 0.08% 101

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Hudock Inc's AGN Position: Q2 2018 in Review

Hudock Inc sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 153 shares — an estimated $25K sold.

Hudock Inc first reported a position in AGN in Q1 2015 and held it in 13 quarters. The position peaked at $210K in Q1 2016. 1,043 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Hudock Inc reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Hudock Inc sold 153 Allergan plc shares in Q2 2018, an estimated $25K.
  • Hudock Inc first reported a position in Allergan plc in Q1 2015 and held it in 13 quarters.
  • Hudock Inc's Allergan plc position peaked at $210K in Q1 2016.
  • 1,043 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Hudock Inc's 13F filing for Q2 2018, filed 1 Aug 2018.